Acclinate Genetics in Huntsville received this week an investment from Birmingham venture capital firm Bronze Valley. The investment will help Acclinate advance its mission of increasing diversity in clinical drug trials. According to a release from Acclinate, “Racial and […]
Originally published on yellowhammernews.com
